An acute myeloid leukemia (AML) rash may appear in the form of small spots or bruises. On light skin, AML rash often appears as red or purple spots. On dark skin, it may look darker and be less ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

Discover how preleukemic stem cells alter the bone marrow microenvironment, promoting leukemia growth. This study reveals key ...

When resistance to or failure of hypomethylating agents (HMAs) occurs in acute myeloid leukemia (AML), depleting a ligase ...

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

THRAP3, STMN1, and GNA13—are overrepresented in blood cancers like acute myeloid leukemia (AML) and could prove to be novel ...

The FDA has granted fast track designation to HC-7366 for the treatment of adult patients with relapsed/refractory acute ...

Unless expressly exempted, AML programs must be applied to all advisory activities. Covered advisers must apply AML programs to all advisory activities, with only a handful of activity- and ...

The trial aims to assess Luvelta's efficacy and safety, with most of its sites due to open by the end of the year.

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

Requirements to remediate the Bank’s U.S. AML program, broadly aligned to its existing remediation program, which is progressing steadily under the direction of its new U.S. AML leadership team.